EndoBarrier TM Gastrointestinal Liner Diabetes Trial
Design and Objective
A new device called the EndoBarrier Gastrointestinal Liner helps patients with diabetes manage their blood sugar levels and lose weight without the need for surgery. This study compares how effective the EndoBarrier device is compared to standard medical care in the treatment of type 2 diabetes mellitus. The study will last for a total of 24 months.
Key inclusion criteria
If you are aged 18-65 years, living with Type 2 Diabetes and have a BMI between 30-50kg/m2, you may be eligible.